BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 17113075)

  • 21. Actions of the systemically active metabotropic glutamate antagonist MPEP on sensory responses of thalamic neurones.
    Binns KE; Salt TE
    Neuropharmacology; 2001 Apr; 40(5):639-44. PubMed ID: 11311891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endogenous activation of mGlu5 metabotropic glutamate receptors contributes to the development of nigro-striatal damage induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
    Battaglia G; Busceti CL; Molinaro G; Biagioni F; Storto M; Fornai F; Nicoletti F; Bruno V
    J Neurosci; 2004 Jan; 24(4):828-35. PubMed ID: 14749427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The mGluR5 antagonist MPEP reduces the conditioned rewarding effects of cocaine but not other drugs of abuse.
    McGeehan AJ; Olive MF
    Synapse; 2003 Mar; 47(3):240-2. PubMed ID: 12494407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antidepressant-like effect of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist in the olfactory bulbectomized rats.
    Wieronska JM; Szewczyk B; Branski P; Palucha A; Pilc A
    Amino Acids; 2002; 23(1-3):213-6. PubMed ID: 12373540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute activation of the spinal cord metabotropic glutamate subtype-5 receptor leads to cold hypersensitivity in the rat.
    Hama AT
    Neuropharmacology; 2003 Mar; 44(4):423-30. PubMed ID: 12646279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [3H]-LY341495 as a novel antagonist radioligand for group II metabotropic glutamate (mGlu) receptors: characterization of binding to membranes of mGlu receptor subtype expressing cells.
    Johnson BG; Wright RA; Arnold MB; Wheeler WJ; Ornstein PL; Schoepp DD
    Neuropharmacology; 1999 Oct; 38(10):1519-29. PubMed ID: 10530814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In the amygdala anxiolytic action of mGlu5 receptors antagonist MPEP involves neuropeptide Y but not GABAA signaling.
    Wierońska JM; Smiałowska M; Brański P; Gasparini F; Kłodzińska A; Szewczyk B; Pałucha A; Chojnacka-Wójcik E; Pilc A
    Neuropsychopharmacology; 2004 Mar; 29(3):514-21. PubMed ID: 14666119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological blockade of mGlu2/3 metabotropic glutamate receptors reduces cell proliferation in cultured human glioma cells.
    D'Onofrio M; Arcella A; Bruno V; Ngomba RT; Battaglia G; Lombari V; Ragona G; Calogero A; Nicoletti F
    J Neurochem; 2003 Mar; 84(6):1288-95. PubMed ID: 12614329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of DOI-induced increases in cortical BDNF expression by group II mGlu receptors.
    Gewirtz JC; Chen AC; Terwilliger R; Duman RC; Marek GJ
    Pharmacol Biochem Behav; 2002 Sep; 73(2):317-26. PubMed ID: 12117585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist.
    Tatarczyńska E; Klodzińska A; Chojnacka-Wójcik E; Palucha A; Gasparini F; Kuhn R; Pilc A
    Br J Pharmacol; 2001 Apr; 132(7):1423-30. PubMed ID: 11264235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function. I. Selective blockade of mGlu5 receptors in models of acute, persistent and chronic pain.
    Walker K; Bowes M; Panesar M; Davis A; Gentry C; Kesingland A; Gasparini F; Spooren W; Stoehr N; Pagano A; Flor PJ; Vranesic I; Lingenhoehl K; Johnson EC; Varney M; Urban L; Kuhn R
    Neuropharmacology; 2001; 40(1):1-9. PubMed ID: 11077065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation by metabotropic glutamate receptor 5 of LTP in the dentate gyrus of freely moving rats: relevance for learning and memory formation.
    Naie K; Manahan-Vaughan D
    Cereb Cortex; 2004 Feb; 14(2):189-98. PubMed ID: 14704216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of repeated withdrawal episodes, nicotine dose, and duration of nicotine exposure on the severity and duration of nicotine withdrawal in rats.
    Skjei KL; Markou A
    Psychopharmacology (Berl); 2003 Jul; 168(3):280-92. PubMed ID: 12712232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolonged nicotine dependence associated with extended access to nicotine self-administration in rats.
    Paterson NE; Markou A
    Psychopharmacology (Berl); 2004 Apr; 173(1-2):64-72. PubMed ID: 14712336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blockade of CRF1 receptors in the central nucleus of the amygdala attenuates the dysphoria associated with nicotine withdrawal in rats.
    Bruijnzeel AW; Ford J; Rogers JA; Scheick S; Ji Y; Bishnoi M; Alexander JC
    Pharmacol Biochem Behav; 2012 Mar; 101(1):62-8. PubMed ID: 22182462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the prototypical mGlu(5) receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine on rotarod, locomotor activity and rotational responses in unilateral 6-OHDA-lesioned rats.
    Spooren WP; Gasparini F; Bergmann R; Kuhn R
    Eur J Pharmacol; 2000 Oct; 406(3):403-10. PubMed ID: 11040347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The anxiolytic action of mGlu2/3 receptor agonist, LY354740, in the fear-potentiated startle model in rats is mechanistically distinct from diazepam.
    Tizzano JP; Griffey KI; Schoepp DD
    Pharmacol Biochem Behav; 2002 Sep; 73(2):367-74. PubMed ID: 12117591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective blockade of mGlu5 metabotropic glutamate receptors is protective against acetaminophen hepatotoxicity in mice.
    Storto M; Ngomba RT; Battaglia G; Freitas I; Griffini P; Richelmi P; Nicoletti F; Vairetti M
    J Hepatol; 2003 Feb; 38(2):179-87. PubMed ID: 12547406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective blockade of metabotropic glutamate receptor subtype 5 is neuroprotective.
    Bruno V; Ksiazek I; Battaglia G; Lukic S; Leonhardt T; Sauer D; Gasparini F; Kuhn R; Nicoletti F; Flor PJ
    Neuropharmacology; 2000 Sep; 39(12):2223-30. PubMed ID: 10974306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endogenous activation of group-I metabotropic glutamate receptors is required for differentiation and survival of cerebellar Purkinje cells.
    Catania MV; Bellomo M; Di Giorgi-Gerevini V; Seminara G; Giuffrida R; Romeo R; De Blasi A; Nicoletti F
    J Neurosci; 2001 Oct; 21(19):7664-73. PubMed ID: 11567056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.